Biological effects of cancer-secreted factors on human mesenchymal stem cells

por Lam, Paula YP
Publicado 2013

Matrix metalloproteinase‐1 facilitates MSC migration via cleavage of IGF‐2/IGFBP2 complex

por Guan, Shou P., Lam, Alan T.L., Newman, Jennifer P., Chua, Kevin L.M., Kok, Catherine Y.L., Chong, Siao T., Chua, Melvin L.K., Lam, Paula Y.P.
Publicado 2017

Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signaling

por Endaya, Berwini, Guan, Shou P., Newman, Jennifer P., Huynh, Hung, Sia, Kian C., Chong, Siao T., Kok, Catherine Y.L., Chung, Alexander Y.F., Liu, Bin B., Hui, Kam M., Lam, Paula Y.P.
Publicado 2017

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

por Chong, Dawn Q, Toh, Xin Y, Ho, Ivy AW, Sia, Kian C, Newman, Jennifer P, Yulyana, Yulyana, Ng, Wai-Hoe, Lai, Siang H, Ho, Mac MF, Dinesh, Nivedh, Tham, Chee K, Lam, Paula YP
Publicado 2015